HAD 6

The cell line is not validated yet.

General

Cell Line

hPSCreg name HADe006-A
Cite as:
HADe006-A (RRID:CVCL_C077)
Alternative name(s)
HAD 6
Cell line type Human embryonic stem cell (hESC)
Similar lines
CBRCULi002-A
(19-1035-10)
Donor diseases:
myotonic dystrophy type 1
CBRCULi003-A
(59-0944-2)
Donor diseases:
myotonic dystrophy type 1
CBRCULi007-A
(14-0730-1)
Donor diseases:
myotonic dystrophy type 1
CBRCULi004-A
(79-1660-2)
Donor diseases:
myotonic dystrophy type 1
CBRCULi005-A
(91-3158-1)
Donor diseases:
myotonic dystrophy type 1
CBRCULi015-A
(GM23375-1, GM23375 clone 1)
Donor's gene variants:
DMPK – DM1 protein kinase, DMPK – DM1 protein kinase
Donor diseases:
Congenital Myotonic Dystrophy
ZZUi015-A
(ZZU-iPS-DM1-002)
Donor diseases:
myotonic dystrophy type 1
CENSOi008-A
(FB77R2c3, CENSOi260)
Donor's gene variants:
DMPK, DMPK
Donor diseases:
myotonic dystrophy type 1
ZZUi006-A
(ZZU-iPS-DM1-001)
Donor's gene variants:
DMPK
Donor diseases:
Steinert myotonic dystrophy
RGIe057-A
(SI-148)
Donor diseases:
myotonic dystrophy type 1
RGIe061-A
(SI-153)
Donor diseases:
myotonic dystrophy type 1
CBRCULi018-A
(91-2032-7)
Donor diseases:
myotonic dystrophy type 1
CHUQi001-A
(522-2666-2, SAMEA104271492)
Donor diseases:
myotonic dystrophy type 1
CBRCULi019-A
(19-1741-2)
Donor diseases:
myotonic dystrophy type 1
CBRCULi020-A
(79-1761-15)
Donor diseases:
myotonic dystrophy type 1
CBRCULi012-A
(GM04601 clone 21, GM04601-21)
Donor diseases:
myotonic dystrophy type 1
CBRCULi013-A
(GM04602-2, GM04602 clone 2)
Donor diseases:
myotonic dystrophy type 1
VUBe003-A
(VUB03_DM1)
Donor diseases:
myotonic dystrophy type 1
KCLe014-A
(KCL018_MD1)
Donor diseases:
myotonic dystrophy type 1
VUBe019-A
(VUB19_DM1)
Donor diseases:
Steinert myotonic dystrophy
HADe001-A
(HAD 1)
Donor diseases:
myotonic dystrophy type 1
Last update 8th February 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Hadassah University Hospital (HAD)
Owner Hadassah Human Embryonic Stem Cell Research Center
Distributors
Derivation country Israel

External Databases

Cellosaurus CVCL_C077
Wikidata Q54872335
BioSamples SAMEA12616337

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex unknown

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Myotonic Dystrophy 1
Synonyms
  • Dystrophia myotonica
  • Steinert disease
  • congenital myotonic dystrophy
  • myotonic dystrophy of Steinert
show more synonyms

External Databases (Donor)

BioSamples SAMEA6621258

Ethics

Was the embryo established purely for research purposes? No
Have both parents consented to the use of the embryo for ESC derivation? Yes
Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Hadassah IRB Committee
Approval number 16-23.04.04
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? No

hESC Derivation

Date of derivation 2007-03-24
Supernumerary embryos from IVF treatment?
No
Other hESC source: IVF
PGD Embryo?
Yes
Derived under xeno-free conditions?
No
Derivation under GMP?
No
Available as clinical grade?
No

Culture Conditions

O2 Concentration 4 %
CO2 Concentration 5 %
Medium Other medium:
Base medium:
Main protein source:
Serum concentration: %

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
Alkaline Phosphatase
Yes
POU5F1 (OCT-4)
Yes

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Unknown

Other Genotyping (Cell Line)